Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor

PURPOSE: Currently, therapeutic tumor vaccines under development generally lack significant effects in human clinical trials. Exploring a powerful antigen delivery system is a potential approach to improve vaccine efficacy. We sought to explore engineered bacterial outer membrane vesicles (OMVs) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shijie, Huang, Weiwei, Li, Kui, Yao, Yufeng, Yang, Xu, Bai, Hongmei, Sun, Wenjia, Liu, Cunbao, Ma, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602458/
https://www.ncbi.nlm.nih.gov/pubmed/28979120
http://dx.doi.org/10.2147/IJN.S143264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602458/
https://www.ncbi.nlm.nih.gov/pubmed/28979120
http://dx.doi.org/10.2147/IJN.S143264

Ejemplares similares